Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug Formulary for Myasthenia Gravis (MG) based on UHPLC-QE-MS Network Pharmacology and Molecular Docking Techniques

Figure 15

Effect of QSDH drug formulary on the expression level of the PI3K/AKT signaling pathway-related proteins in EAMG rats. (Figure a shows the significant analysis of PI3K and p-PI3K protein expression in the spleen tissues of rats in each experimental group, Figure b shows the significant analysis of AK and p-AKT protein expression in the spleen tissues of rats in each experimental group, and Figure c shows the expression of related proteins in the spleen tissues of rats in each experimental group by Western blot. Comparison of the EAMG model group with adjuvant control group  < 0.01. QSDH drug formulary each dose group compared with the EAMG model group # < 0.05, ^## < 0.01).

(a)

(b)

(c)